BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21959339)

  • 1. Current and future avoidable cost of smoking--estimates for Sweden 2007.
    Bolin K; Borgman B; Gip C; Wilson K
    Health Policy; 2011 Nov; 103(1):83-91. PubMed ID: 21959339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smoking attributable medical expenditures, years of potential life lost, and the cost of premature death in Taiwan.
    Yang MC; Fann CY; Wen CP; Cheng TY
    Tob Control; 2005 Jun; 14 Suppl 1(Suppl 1):i62-70. PubMed ID: 15923452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smoking, healthcare cost, and loss of productivity in Sweden 2001.
    Bolin K; Lindgren B
    Scand J Public Health; 2007; 35(2):187-96. PubMed ID: 17454923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The economic burden of smoking in California.
    Max W; Rice DP; Sung HY; Zhang X; Miller L
    Tob Control; 2004 Sep; 13(3):264-7. PubMed ID: 15333882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality, morbidity and costs attributable to smoking in Germany: update and a 10-year comparison.
    Neubauer S; Welte R; Beiche A; Koenig HH; Buesch K; Leidl R
    Tob Control; 2006 Dec; 15(6):464-71. PubMed ID: 17130376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost of tobacco-related diseases, including passive smoking, in Hong Kong.
    McGhee SM; Ho LM; Lapsley HM; Chau J; Cheung WL; Ho SY; Pow M; Lam TH; Hedley AJ
    Tob Control; 2006 Apr; 15(2):125-30. PubMed ID: 16565461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the cost of smoking to the NHS in England and the impact of declining prevalence.
    Callum C; Boyle S; Sandford A
    Health Econ Policy Law; 2011 Oct; 6(4):489-508. PubMed ID: 20735898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Workplace smoking related absenteeism and productivity costs in Taiwan.
    Tsai SP; Wen CP; Hu SC; Cheng TY; Huang SJ
    Tob Control; 2005 Jun; 14 Suppl 1(Suppl 1):i33-7. PubMed ID: 15923446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The public health impact and economic cost of smoking in Connecticut--1989.
    Adams ML
    Conn Med; 1994 Apr; 58(4):195-8. PubMed ID: 8045117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cigarette smoking and lifetime medical expenditures.
    Hodgson TA
    Milbank Q; 1992; 70(1):81-125. PubMed ID: 1588892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost of smoking in Canada, 1991.
    Kaiserman MJ
    Chronic Dis Can; 1997; 18(1):13-9. PubMed ID: 9188515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling the health benefits of smoking cessation in Japan.
    Avila-Tang E; Apelberg BJ; Yamaguchi N; Katanoda K; Sobue T; Samet JM
    Tob Control; 2009 Feb; 18(1):10-7. PubMed ID: 18728096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.
    Tyo KR; Rosen MM; Zeng W; Yap M; Pwee KH; Ang LW; Shepard DS
    Vaccine; 2011 Sep; 29(38):6686-94. PubMed ID: 21745516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Smoking-attributable productivity loss in Germany--a partial sickness cost study based on the human capital potential method].
    Wegner C; Gutsch A; Hessel F; Wasem J
    Gesundheitswesen; 2004 Jul; 66(7):423-32. PubMed ID: 15314734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost of smoking for California's Hispanic community.
    Max W; Sung HY; Tucker LY; Stark B
    Nicotine Tob Res; 2011 Apr; 13(4):248-54. PubMed ID: 21330281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smoking attributable mortality and economic costs in Alaska 1992-94.
    Schumacher C
    Alaska Med; 1996; 38(1):13-7. PubMed ID: 8936095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes, healthcare cost and loss of productivity in Sweden 1987 and 2005--a register-based approach.
    Bolin K; Gip C; Mörk AC; Lindgren B
    Diabet Med; 2009 Sep; 26(9):928-34. PubMed ID: 19719715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Varenicline as compared to bupropion in smoking-cessation therapy--cost-utility results for Sweden 2003.
    Bolin K; Mörk AC; Willers S; Lindgren B
    Respir Med; 2008 May; 102(5):699-710. PubMed ID: 18289839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic consequences of HIV/AIDS in India.
    Pandav CS; Anand K; Shamanna BR; Chowdhury S; Nath LM
    Natl Med J India; 1997; 10(1):27-30. PubMed ID: 9069706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct hospital resource utilization and costs of treating patients with multiple myeloma in Southwest Sweden: a 5-year retrospective analysis.
    Ghatnekar O; Alvegård T; Conradi N; Lenhoff S; Mellqvist UH; Persson U; Löthgren M
    Clin Ther; 2008 Sep; 30(9):1704-13. PubMed ID: 18840377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.